The present invention relates to the treatment of disorders using pharmaceutical agents in combination with heme oxygenase- 1 and/or heme degradation products, such as biliverdin or carbon monoxide.
申请公布号
WO2008008513(A2)
申请公布日期
2008.01.17
申请号
WO2007US16032
申请日期
2007.07.12
申请人
BETH ISRAEL DEACONESS MEDICAL CENTER INC.;BACH, FRITZ, H.;HASCHEMI, ARVAND;OTTERBEIN, LEO, E.
发明人
BACH, FRITZ, H.;HASCHEMI, ARVAND;OTTERBEIN, LEO, E.
